Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/07/054994
CTRI/2023/07/054994
Recruiting
Phase 2

A Clinical study to Evaluate the Efficacy and Safety ofUnani Formulation (Itrifal Mulayyin) in the managementof Shaqiqa Muzmin (Chronic Migraine) - NI

State Unani Medical College, Himmatganj Prayagraj0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: G438- Other migraine

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: G438- Other migraine
Sponsor
State Unani Medical College, Himmatganj Prayagraj
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
State Unani Medical College, Himmatganj Prayagraj

Eligibility Criteria

Inclusion Criteria

  • •1\. Clinically diagnosed Patients with chronic migraine as per ICHD criteria
  • •2\.Patients aged between 18\-60 years
  • •3\. Either gender
  • •4\. Willing to fill daily headache diary
  • •5\. Patient willing to sign written informed consent

Exclusion Criteria

  • •1\. Non\-migrainous headache: tension\-type headache; cluster headache; chronic
  • •paroxysmal or non\-paroxysmal hemicranias
  • •2\. Familial hemiplegic migraine
  • •3\. Below 18 and above 60 years
  • •4\. Pregnancy and Lactating women
  • •5\. Patients with Neuropsychiatric illness
  • •6\. Patients with significant co\-morbidity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Treatment of ithy, red, dry and cracked skin condition (Eczema) by of Unani drug
CTRI/2017/12/010957Central Research Institute of Unani Medicine
Completed
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis BullosaEpidermolysis Bullosa
JPRN-UMIN000026645Osaka University6
Completed
Phase 2
Clinical comparative efficacy and safety of Polyherbal Unani formulations.Health Condition 1: K120- Recurrent oral aphthae
CTRI/2023/02/049696State Unani Medical College, himmatganj Prayagraj40
Not yet recruiting
Phase 2
Effectiveness of Unani Drugs in High Blood Pressure
CTRI/2017/12/011006Central Research Institute of Unani Medicine
Active, not recruiting
Not Applicable
Study Evaluating Rapamune® Maintenance RegimeRenal transplantationMedDRA version: 17.1Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
EUCTR2014-004101-33-Outside-EU/EEAWyeth Korea, Inc.79